Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bedaquiline, Moxifloxacin, PA-824, and Pyrazinamide in Pulmonary Tuberculosis
NCT02193776Phase 2Completed
- Sponsor
- TB Alliance
- Start
- Oct 2014
- Primary completion
- Feb 2016
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of pretomanid in pulmonary tuberculosis (TB), sponsored by TB Alliance. Started Oct 2014; status: completed.
02
Drugs
pretomanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02193776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193776.